ClinicalTrials.Veeva

Menu

Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease (PACE)

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Completed

Conditions

Focus Chronic Kidney Disease With Hypertension

Treatments

Behavioral: Exercise

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02112825
1207M17821
R03DK097318 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The general objective of the study is to investigate the effect of regular aerobic exercise on resting and 24-hr blood pressure levels in men and women with stage 3-4 kidney disease and hypertension.

Enrollment

40 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • Non-diabetic and >18 years of age

    • Diagnosed kidney disease with associated hypertension:
    • Non-nephrotic range proteinuria at diagnosis
    • No active glomerular disease or concomitant systemic inflammatory disease (e.g. lupus)
    • Systolic blood pressure >130 and/or diastolic blood pressure >80 mm Hg (on medication)
    • An estimated glomerular filtration rate of between 60 ml/min and 15 ml/min.
    • Individuals must be able to provide informed consent
    • Perform walking exercise training on a treadmill
    • Be able to participate in a 12-week supervised exercise program.

Exclusion criteria

  • Currently participating in a formal exercise program
  • Diabetes, active glomerular disease, or systemic inflammatory disease
  • Requiring dialysis
  • Have an Hematocrit <27%
  • Uncontrolled hypertension (>200/110mmHg)
  • Peripheral vascular disease.
  • An inability to understand English or give consent. Other exclusion criteria are: any contraindications to exercise testing or training as indicated by the American College of Sports Medicine guidelines such as: Unstable coronary heart disease and symptomatic heart failure, exercise capacity limited by health problems such as angina, severe arthritis, or extreme dyspnea on exertion, progressive neuromuscular disease, pulmonary disease, or having undergone a coronary revascularization within the past 6 months prior to enrollment.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Exercise
Experimental group
Description:
12 weeks of blended supervised-home based exercise 3-4 times per week for 30-45 minutes
Treatment:
Behavioral: Exercise
control
No Intervention group
Description:
Control group asked to continue usual activities

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems